International Stem Cell (ISCO) Treasury Shares (2011 - 2026)
International Stem Cell (ISCO) posted quarterly Treasury Shares of $1.0 million for Q3 2025, little changed year-over-year from $1.0 million in Q3 2024, and little changed quarter-over-quarter from $1.0 million in Q2 2025.
International Stem Cell (ISCO) Treasury Shares (2011 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Treasury Shares for 13 consecutive years, with $1.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Treasury Shares changed 0.0% year-over-year to $1.0 million; the TTM figure through Sep 2025 stood at $1.0 million (changed 0.0% YoY), while the FY2025 annual figure was $1.0 million, up 2325481.4% from the prior year.
- Treasury Shares held at $1.0 million in Q3 2025 per ISCO's latest filing, from $1.0 million in the prior quarter.
- Across five years, Treasury Shares topped out at $1.0 million in Q2 2024 and bottomed at $43.0 in Q1 2021.
- Historically, Treasury Shares has averaged $263189.6 across 5 years, with a median of $43.0 in 2021.
- Annual changes were most pronounced in 2021 — Treasury Shares changed 0.0% — and 2024, when it surged 2325481.4%.
- International Stem Cell's Treasury Shares stood at $43.0 in 2021, then changed by 0.0% to $43.0 in 2022, then changed by 0.0% to $43.0 in 2023, then changed by 0.0% to $43.0 in 2024, then soared by 2325481.4% to $1.0 million in 2025.
- Business Quant data shows ISCO's Treasury Shares at $1.0 million in Q3 2025, $1.0 million in Q2 2025, and $1.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 2.72 Mn |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Jun 30, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 43.00 |
| Dec 31, 2024 | 43.00 |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 43.00 |
| Mar 31, 2024 | 43.00 |
| Dec 31, 2023 | 43.00 |
| Dec 31, 2023 | 43.00 |